YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 54.10
+1.00 (1.88%)
Mar 26, 2026, 1:30 PM CST
YungShin Global Holding Market Cap
YungShin Global Holding has a market cap or net worth of 14.41 billion as of March 26, 2026. Its market cap has increased by 4.24% in one year.
Market Cap
14.41B
Enterprise Value
14.32B
Revenue
8.37B
Ranking
n/a
PE Ratio
14.96
Stock Price
54.10
Market Cap Chart
Since January 4, 2011, YungShin Global Holding's market cap has increased from 10.25B to 14.41B, an increase of 40.61%. That is a compound annual growth rate of 2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 14.41B | -5.09% |
| Dec 31, 2025 | 15.18B | 5.75% |
| Dec 31, 2024 | 14.36B | 15.91% |
| Dec 29, 2023 | 12.39B | 1.09% |
| Dec 30, 2022 | 12.25B | 7.10% |
| Dec 30, 2021 | 11.44B | -3.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 31.24B |
| TTY Biopharm Company | 19.82B |
| Grape King Bio | 17.78B |
| ScinoPharm Taiwan | 16.45B |
| Synmosa Biopharma | 15.45B |
| Foresee Pharmaceuticals | 12.18B |
| Alar Pharmaceuticals | 11.39B |
| Standard Chemical & Pharmaceutical | 11.22B |